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1. Introduction 
Carcinoembryonic antigen (CEA) has been isolated 
from perchloric acid (PCA) extracts of colonic carci- 
noma, their metastases to the liver [ 1,2] and, in lim- 
ited amounts, from PCA extracts of normal colon [3]. 
Purified CEA has been shown to be a glycoprotein 
containing asignificant amount of carbohydrate by 
weight [ 1,2]. CEA shows a 7-8 S se~entation coeffi- 
cient in the ultracentrifuge and av. mol. wt 200 000 
as judged by gel filtration and sodium dodecyl sulfate 
(SDS)-polyacrylamide gel electrophoresis (PAGE) [4]. 
Purified CEA, when assessed by PAGE, isoelectric 
focusing, or SDS-PAGE, shows considerable elec- 
trophoretic heterogeneity, often giving a single broad 
migrating zone [5]. Neuraminidase treatment reduces 
the extent of polydisperity observed by PAGE and 
isoelectric focusing, but not completely [5]. SDS-PAGE 
heterogeneity ismore difficult to assess. Eiectro- 
phoretic mobility differences observed by this tech- 
nique could be due to differences in the polypeptide 
molecular weight, unequal binding of SDS or differ- 
ences in the content and composition of covalently- 
bound carbohydrate. We have noted a striking and 
reproducible bimodal distribution of molecular 
species when commercially-available ‘%radio- 
labeled CEA(1251-CEA) was analyzed by SDS-PAGE. 
We have attempted to utilize this difference in SDS- 
PAGE mobility to determine first, whether both 
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species were reactive with specific antisera, and, 
second, whether this system could be used to study 
subtle differences in CEA antigicity. CEA antigenic 
heterogeneity has been proposed [6]; several CEA 
standards and their corresponding antisera were com- 
pared by radioisotopic ompetition studies. Their 
results uggested that isoantigens of CEA exist, and 
available antisera re probably polyspecific for these 
variations. 
Commerc~~ava~able ‘251-CEA standard was 
compared by immunoprecipitation with three dif- 
f&ent anti-CEA sera, and the precipitates were ana- 
lyzed by SDS-PAGE. The results uggest that the 
SDS electrophoretic bimodal mobilities cannot be 
explained by isoantigenic differences and that both 
molecular species characterized by SDS-PAGE are 
precipitable with anti-CEA. 
2. Materials and methods 
2.1= Antisera 
Antisera produced in goats against CEA were 
obtained from several sources. Two different prepa- 
rations of Roche anti-CEA were obtained, one from 
the commercially-available kit (QC no. 77436, 
Hoffman-LaRoche, Nutley NJ) and another (183.TM) 
kindly supplied by Drs D. Haagensen (Duke University) 
and J. Primus (Hoffman-LaRoche). Hope goat anti- 
CEA (Ace 67-70) was obtained from Drs M. Egan 
and C. Todd (City of Hope National Medical Center, 
Duarte, CA), and Montreal goat anti-CEA was sup 
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plied by Dr P. Gold (McGill University Medical School, 
Montreal). An aliquot of the Hope anti-CEA was 
absorbed with a perchloric acid extract of a normal 
human spleen homogenate as suggested byDr M. Egan. 
Rabbit anti goat IgG was purchased from Miles 
Laboratories, Inc. (Elkhart, IN). Each lot was titrated 
by quantitative immunoprecipitation against goat IgG 
and used in assay systems at equivalence. 
2.2. Carcinoembryonic antigen (CEA) sources 
Three preparations ofRoche ‘2SI-CEA were obtained 
from Hoffman-LaRoche (QC no. 0317-09086, 
QC 0109-02256 and QC 0173.05187). 
2.3. Immunoprecipitation 
Precipitation of r2’ I-CEA was performed in calf 
serum (Grand Island Biological Co .)-coated 6X 50 mm 
test tubes as suggested by Dr Peter Cresswell (personal 
communication). Generally, 5 4 undiluted antiserum 
was added to 50-100 ~1 12’I-CEA, and sufficient 
rabbit anti-goat IgG was added to achieve maximal 
precipitation of the goat IgG (- 100 ~1, depending on 
the titer of the antiglobulin). This mixture was incu- 
bated at 4°C overnight. 
The precipitates were centrifuged at 1000 rev./min 
for 5 min in an IEC table-top centrifuge and washed 
3 times in Dulbecco’s phosphate-buffered saline, 
pH 7.0 (Grand Island Biological Co.). A final wash 
was done in distilled water. The initial mixture, wash 
supematants and final pellet were counted for “‘1. 
The final pellet was dissolved in 100 /.d sample 
buffer containing SDS, &mercaptoethanol and bromo- 
phenol blue tracking dye as in [‘i’], and heated in a 
boiling water bath for 2-5 min. Analysis was per- 
formed by SDS-PAGE utilizing a discontinuous 
buffer system [7]. 
2.4. SDS-PAGE 
The immune precipitates dissolved as above or 
lo-50 ~1 12’I-CEA in sample-reducing buffer (total 
100 ~1) were applied to polyacrylamide gel-containing 
tubes of a Buchler Polyanalyst Disc Electrophoresis 
Apparatus (Buchler Instruments, Ft. Lee NJ). The 
conditions for discontinuous PAGE, electrophoretic 
stacking and polypeptide separation have been 
detailed [7]. Generally, 3% polyacrylamide stacking 
gels and either 5% or 7.5% resolving els were used. 
Following electrophoresis, the polyacrylamide gels 
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were removed from the tubes, frozen and sliced with 
a Bio-Rad 190 gel slicer (Bio-Rad Laboratories, 
Richmond, CA). Sections of 1 mm were loaded into 
12 X 75 mm disposable test tubes and counted for 
lz51 on a Searle 1185 series gamma counter 
(Des Plaines IL). 
Protein standards were simultaneously electro- 
phoresed, and these gels were stained with Coomassie 
brilliant blue. Rabbit muscle myosin was prepared in 
our laboratory as in [8]. Human transferrin and hen 
ovalbumin were purchased from Sigma Chemical Co. 
(St Louis MO), and P-galactosidase was obtained from 
Worthington Biochemical Corp. (Freehold NJ). 
3. Results 
Preliminary experiments were performed to establish 
conditions where the radiolabeled antigen was in slight 
excess with respect o anti-CEA. The amount of anti- 
serum used was designed to give 30-60% precipita- 
tion of radiolabeled CEA (table l), a range chosen to 
optimize the detection of antigenic variability. Hope 
anti-CEA was used before and after absorption with a 
perchloric acid extract of normal human spleen 
homogenate. The titer of the Hope antiserum fell 
2-fold following absorption due to dilution (data not 
shown), and a correspondingly greater amount of 
Table 1 
% ‘*SI-radiolabeled CEA precipitated with three different 
antisera for use in SDS-PAGE analysisa 
- 
AntiCEA Mean % cpm No. exp. 
precip. +- SD 
Roche 34.3 f 8.7 10 
Hope unabs. 55.3 f 0.4 2 
Hope absb 54.7 f 2.8 2 
Montreal 50.5 f 1.6 2 
Normal goat serum 1.9 f 0.1 2 
a Preliminary titration experiments were performed to establish 
conditions where radiolabeled antigen was in slight excess 
with respect to specific antibody (data not shown) 
b Hope antiCEA was assayed before and after absorption 
with a perchloric acid extract of human spleen homogenate 
(section 2) 
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Fig.1. SDS-PAGE analyses of ‘ZsICEA (0-u) and immune 
precipitated “‘ICEA (e-a). 50 ~1 SDS-treated labeled CEA 
was run directly. Another 50 ~1 aliquot was precipitated with 
Montreal antiCEA and rabbit anti-goat IgG. The immune 
precipitate was dissolved in SDS buffer and treated as 
described in section 2.5% resolving gels were used, and a 
calibration curve of mobility versus polypeptide molecular 
weight was established with myosin heavy chain (mol. wt 
210 000), Pgalactosidase (mol. wt 135 000) and human 
transferrin (mol. wt 79 000). The ‘“‘I cpm/l mm slice are 
plotted versus the fraction (slice) number. * 
Table 2 
Apparent molecular weights of “*I-radiolabeled CEA as 
assessed by SDS-PAGEa 
Gel system First peak Second peak No. samples 
mol. wt f SD mol. wt f SD analyzedb 
(X 10-3) (X 10-3) 
5.0% acrylamide 173.9 ?r 13.4 130.5 f 8.2 22 
7.5% acrylamide 173.7 f 11.0 138.0 f 4.2 4 
a The apparent molecular weight was calculated from standard 
curves relating the SDS-electrophoretic mobility of stan- 
dard proteins to known polypeptide molecular weights. This 
method is not generally valid for glycoproteins containing 
significant covalent carbohydrate by weight 
b Data from specific immune precipitation analyses and from 
untreated CEA analyses are included, and represent experi- 
ments performed over 1 year. Three Roche ‘151CEA sam- 
ples are included in these results 
absorbed Hope anti-CEA was used in subsequent 
studies. 
Figure 1 shows representative data for SDS-PAGE 
analysis of Roche 12JI-CEA on 5% polyacrylamide 
gels [7], and for a similar analysis of an SDS-solu- 
bilked CEA anti-CEA immune precipitate. Montreal 
anti-CEA was used in this illustration, however, iden- 
tical data were obtained with Roche, absorbed Hope 
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Fig.2. SDS-PAGE analyses of immune precipitated “‘ICEA. 
Precipitates were formed with ‘251CEA, Roche antiCEA 
(e-e) or normal goat serum (u-o), and rabbit anti-goat IgG. 
The precipitates were washed, counted (see table l), solu- 
bilized with SDS sample reducing buffer and treated as 
described in section 2. Either 7.5% (A) or 5% (B) polyacryl- 
amide resolving gels were used. Calibration curves were 
established from the migration of myosin heavy chain, 
pgalactosidase, human transferrin and hen ovalbumin (mol. 
wt 45 000). The ‘*‘I cpm/l mm slice are plotted versus the 
fraction (slice) number. 
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and unabsorbed Hope anti-CEA. Figure 2 shows 
SDS-PAGE profiles of ‘251-CEA precipitated with 
Roche anti-CEA and with normal goat serum as a 
control. The bimodal distribution ofimmune pre- 
cipitated species was observed on both 5% and 7.5% 
polyac~lamide gels, and was indi$tIngui~able from 
the results for SDS-treated ‘251-CEA run alone. 
Although CEA is heavily glycosylated, there did 
not seem to be a large effect of polyacryiamide con- 
centration (over a limited range) on apparent molec- 
ular weight (table 2). 
4. Discussion 
SDS-PAGE analyses of Roche r2%CEA consis- 
tently gave a bimodal pattern of el~ctrophoret~c 
mobilities (fig. 1). We hypothesized that these species 
might be antigenically distinct, in that Roche ‘%CEA 
and CEA standards were distinct [6] from other 
available CEA standards by radioimmune competition 
assay. We establi~ed conditions which gave a similar 
an~gen-to-~tib~y ratio utilized in [6f, and compared 
‘2SI-CEA with specifically-precipitated ‘%33A on 
SDS-PAGE. Regardless of the source of anti-CEA, 
we could not distinguish any differences in 12’ I-CEA 
and i~une-precipitated material by this method. 
Radiolabeled material in both peaks of the bimodal 
distribufion seem equalIy reactive with all anti-CEA 
sera tested (fig. 1,2A, 2B and data not shown) in that 
the ratio of the two peaks was always the same, 
The possibility that the bimodal distribution results 
from an artifact of the chloramine T oxidation method 
for labeling CEA seems unlikely. In unpubIi~ed 
results, we have determined that CEA labeled by 
either the chloramine T oxidation method [9] or by 
the gentle acylating method [lo] is identical. We con- 
chide that the differences in SDS-PAGE mobility are 
not due to contaminating molecules or to antigenic 
variants, but are related to physical differences (poly- 
peptide molecular weight or molecules of SDS bound 
per molecule of CEA) or to chemical differences (con- 
tent and ~ompo~tion of the covalently-bound carbo- 
hydrate). 
This work was supported by grant no. IM-94 from 
the American Ca.icer Society. 
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